Activation of NK Cells in Mixed Cultures of Wharton’s Jelly Mesenchymal Stromal Cells and Peripheral Blood Lymphocytes
- Authors: Svirshchevskaya E.V.1, Poltavtsev A.M.2, Os’mak G.Z.3, Poltavtseva R.A.3
- 
							Affiliations: 
							- M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
- Institute of Applied Mechanics, Russian Academy of Sciences
- V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of the Health of the Russian Federation
 
- Issue: Vol 164, No 3 (2018)
- Pages: 339-343
- Section: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/239587
- DOI: https://doi.org/10.1007/s10517-018-3985-1
- ID: 239587
Cite item
Abstract
Mesenchymal stromal cells possess immunosuppressive properties that might be used for the therapy of inflammatory diseases of various geneses. The effects of mesenchymal stromal cells depend on their lifetime in the recipient tissues. During heterologous transplantation, mesenchymal stromal cells are eliminated by NK cells. We studied NK cell formation in mixed cultures of Wharton’s jelly mesenchymal stromal cells and peripheral blood lymphocytes from an autologous donor. Lymphocytes were activated by a mitogen or IL-2. The lifetime of mesenchymal stromal cells was estimated by MTT test. Cytotoxic activity and phenotype of NK cells were evaluated by flow cytometry. It was found that activation of NK cells depended on IL-2 and was registered on day 2 of incubation with IL-2. In cultures with mitogen-activated lymphocytes, cytotoxicity was observed after 5-6 days. Cytotoxicity of NK correlated with significant decrease in CD16+ and increase in CD56+ NK and with reduction of mesenchymal stromal cell viability. Thus, the main mechanism of elimination of mesenchymal stromal cells is cytotoxicity of NK cells that depended on IL-2 production.
About the authors
E. V. Svirshchevskaya
M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
							Author for correspondence.
							Email: esvir@mx.ibch.ru
				                					                																			                												                	Russian Federation, 							Moscow						
A. M. Poltavtsev
Institute of Applied Mechanics, Russian Academy of Sciences
														Email: esvir@mx.ibch.ru
				                					                																			                												                	Russian Federation, 							Moscow						
G. Zh. Os’mak
V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of the Health of the Russian Federation
														Email: esvir@mx.ibch.ru
				                					                																			                												                	Russian Federation, 							Moscow						
R. A. Poltavtseva
V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of the Health of the Russian Federation
														Email: esvir@mx.ibch.ru
				                					                																			                												                	Russian Federation, 							Moscow						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					